Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
41 hedge funds and large institutions have $9.28M invested in Molecular Templates, Inc. in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 14 closing their positions.
1% more capital invested
Capital invested by funds: $9.21M → $9.28M (+$72.5K)
18% less funds holding
Funds holding: 50 → 41 (-9)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carlyle Group
Washington,
District of Columbia
|
+$90K |
| 2 |
Morgan Stanley
New York
|
+$10.2K |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$9.54K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.21K |
| 5 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$4.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$597K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$336K |
| 3 |
Two Sigma Advisers
New York
|
-$59.6K |
| 4 |
Two Sigma Investments
New York
|
-$52.9K |
| 5 |
Renaissance Technologies
New York
|
-$40.8K |
MTEM Hedge Fund Activity: Q1 2023 in Review
41 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q1 2023, worth a combined $9.28M — up 0.79% from $9.21M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of MTEM and 6 opened new positions — a net loss of 8 holders — while 8 trimmed existing stakes and 3 added.
The largest buyer was Carlyle Group, opening a new position worth an estimated $90K. The largest seller was Pictet Asset Management (Switzerland), exiting entirely with an estimated $597K sold.
- 41 institutional investors held Molecular Templates, Inc. (MTEM) as of Q1 2023, down from 50 in Q4 2022.
- Funds reported $9.28M of Molecular Templates, Inc. stock for Q1 2023, up 0.79% quarter-over-quarter.
- 6 funds opened new Molecular Templates, Inc. positions in Q1 2023 and 14 closed out, a net change of -8 holders.
- The largest Molecular Templates, Inc. buyer in Q1 2023 was Carlyle Group, an estimated $90K added.
- The largest Molecular Templates, Inc. seller in Q1 2023 was Pictet Asset Management (Switzerland), an estimated $597K sold.
Based on aggregated 13F filings for Q1 2023.